Review
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility
Affiliations
- PMID: 17137007
Item in Clipboard
Review
Genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility
Am Fam Physician.
.
Free article
No abstract available
Similar articles
-
Mutations of BRCA genes in hereditary breast and ovarian cancer.J Exp Clin Cancer Res. 2002 Sep;21(3 Suppl):9-12. J Exp Clin Cancer Res. 2002. PMID: 12585647 Review.
-
Optimal selection of individuals for BRCA mutation testing.J Clin Oncol. 2006 Jul 10;24(20):3311; author reply 3311-2. doi: 10.1200/JCO.2006.06.6134. J Clin Oncol. 2006. PMID: 16829657 No abstract available.
-
[In familial breast or ovarian carcinoma: normal cancer prevention is not enough].MMW Fortschr Med. 2004 Apr 8;146(15):12. MMW Fortschr Med. 2004. PMID: 15373015 German. No abstract available.
-
DNA testing. Genetic screen misses mutations in women at high risk of breast cancer.Science. 2006 Mar 31;311(5769):1847. doi: 10.1126/science.311.5769.1847a. Science. 2006. PMID: 16574828 No abstract available.
-
Decisions and ethical issues among BRCA carriers and the use of preimplantation genetic diagnosis.Minerva Med. 2009 Oct;100(5):371-83. Minerva Med. 2009. PMID: 19910890 Review.
Cited by
-
SMAD4 expression in breast ductal carcinoma correlates with prognosis.Oncol Lett. 2015 Sep;10(3):1709-1715. doi: 10.3892/ol.2015.3442. Epub 2015 Jul 1. Oncol Lett. 2015. PMID: 26622737 Free PMC article.
-
Applying the 2011 Canadian guidelines for breast cancer screening in practice.CMAJ. 2012 Nov 6;184(16):1803-7. doi: 10.1503/cmaj.120392. Epub 2012 Sep 10. CMAJ. 2012. PMID: 22966059 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
